Synopsys (NASDAQ:SNPS) Raised to “Strong-Buy” at Zacks Research

Posted by Brian Himes on Jul 2nd, 2026

Synopsys (NASDAQ:SNPS – Get Free Report) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.

Other analysts have also recently issued research reports about the company. Berenberg Bank set a $633.00 target price on Synopsys in a research report on Wednesday, May 27th. Rosenblatt Securities upped their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Citigroup raised their target price on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Wells Fargo & Company upped their price objective on shares of Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $570.06.

Check Out Our Latest Research Report on SNPS

Synopsys Trading Up 1.9%

NASDAQ:SNPS opened at $454.53 on Tuesday. The business has a fifty day moving average of $483.60 and a 200-day moving average of $461.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a market cap of $87.03 billion, a price-to-earnings ratio of 105.22, a PEG ratio of 2.62 and a beta of 1.22. Synopsys has a 1 year low of $376.18 and a 1 year high of $651.73.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the company earned $3.67 earnings per share. Synopsys’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts predict that Synopsys will post 10.65 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Synopsys

A number of institutional investors have recently modified their holdings of the stock. Sankala Group LLC bought a new stake in shares of Synopsys during the fourth quarter worth $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys during the 4th quarter valued at $28,000. IMG Wealth Management Inc. acquired a new position in shares of Synopsys in the 1st quarter valued at $30,000. Finally, Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $32,000. 85.47% of the stock is owned by institutional investors.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.